Yes - IHL is on a rapid rerate path here IMO and on a comparison...

Yes - IHL is on a rapid rerate path here IMO and on a comparison basis with AGH and BOT re revenue. projects, trials, licensing deals and caliber of peope involved, including Sud from Cannvalate, this has to be the best risk/reward stock in a fast growing sector to invest in IMO.

News over the weekend focusing on Govt stepping up to the plate in the medicinal cannabis sector. As posted earlier. I attended the Cannabis Society Forum the other week where industry leaders were speaking - including Sud, our new Director; IHL is IMO on its way to be a, if not "the"leader, in medicinal cannabis. I can see IHL surpassing AGH and BOT MC quite quickly given their projects and ability to implement.